BIOMARKERS AND USES THEREOF IN THE TREATMENT OF CHRONIC HBV INFECTION
Immunogenetic biomarkers of viral control of chronic hepatitis B (CHB) infection that are indicative of relapse after a viral suppression treatment, such as a NUC treatment, in CHB infected subject are described. Also described are methods and compositions of using the immunogenetic biomarkers in pr...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TUEFFERD, Marianne Isabelle CRABBE, Marjolein AERSSENS, Jeroen Marcel Maria Roger BOLLEKENS, Jacques Armand Henri DI CARA, Alessandro |
| description | Immunogenetic biomarkers of viral control of chronic hepatitis B (CHB) infection that are indicative of relapse after a viral suppression treatment, such as a NUC treatment, in CHB infected subject are described. Also described are methods and compositions of using the immunogenetic biomarkers in predicting the relapse in the viral suppression treatment of CHB infection.
L'invention concerne des biomarqueurs immunogénétiques de la régulation virale d'une infection à hépatite B chronique (HBC) qui indiquent une rechute après un traitement de suppression virale, tel qu'un traitement par NUC, chez un sujet infecté par l'HBC. L'invention concerne également des compositions et des méthodes d'utilisation de ces biomarqueurs immunogénétiques pour prédire la rechute dans le traitement de suppression virale d'une infection à HBC. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022049504A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022049504A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022049504A23</originalsourceid><addsrcrecordid>eNrjZHB18vT3dQzydg0KVnD0c1EIDXYNVgjxcA1y9XdT8PQDMRVCglwdQ3xd_UIUgGLOHkH-fp7OCh5OYUB5N1fnEE9_Px4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh_ub2RgZGRgYmlqYOJoZEycKgAR1Syr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BIOMARKERS AND USES THEREOF IN THE TREATMENT OF CHRONIC HBV INFECTION</title><source>esp@cenet</source><creator>TUEFFERD, Marianne Isabelle ; CRABBE, Marjolein ; AERSSENS, Jeroen Marcel Maria Roger ; BOLLEKENS, Jacques Armand Henri ; DI CARA, Alessandro</creator><creatorcontrib>TUEFFERD, Marianne Isabelle ; CRABBE, Marjolein ; AERSSENS, Jeroen Marcel Maria Roger ; BOLLEKENS, Jacques Armand Henri ; DI CARA, Alessandro</creatorcontrib><description>Immunogenetic biomarkers of viral control of chronic hepatitis B (CHB) infection that are indicative of relapse after a viral suppression treatment, such as a NUC treatment, in CHB infected subject are described. Also described are methods and compositions of using the immunogenetic biomarkers in predicting the relapse in the viral suppression treatment of CHB infection.
L'invention concerne des biomarqueurs immunogénétiques de la régulation virale d'une infection à hépatite B chronique (HBC) qui indiquent une rechute après un traitement de suppression virale, tel qu'un traitement par NUC, chez un sujet infecté par l'HBC. L'invention concerne également des compositions et des méthodes d'utilisation de ces biomarqueurs immunogénétiques pour prédire la rechute dans le traitement de suppression virale d'une infection à HBC.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220310&DB=EPODOC&CC=WO&NR=2022049504A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220310&DB=EPODOC&CC=WO&NR=2022049504A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TUEFFERD, Marianne Isabelle</creatorcontrib><creatorcontrib>CRABBE, Marjolein</creatorcontrib><creatorcontrib>AERSSENS, Jeroen Marcel Maria Roger</creatorcontrib><creatorcontrib>BOLLEKENS, Jacques Armand Henri</creatorcontrib><creatorcontrib>DI CARA, Alessandro</creatorcontrib><title>BIOMARKERS AND USES THEREOF IN THE TREATMENT OF CHRONIC HBV INFECTION</title><description>Immunogenetic biomarkers of viral control of chronic hepatitis B (CHB) infection that are indicative of relapse after a viral suppression treatment, such as a NUC treatment, in CHB infected subject are described. Also described are methods and compositions of using the immunogenetic biomarkers in predicting the relapse in the viral suppression treatment of CHB infection.
L'invention concerne des biomarqueurs immunogénétiques de la régulation virale d'une infection à hépatite B chronique (HBC) qui indiquent une rechute après un traitement de suppression virale, tel qu'un traitement par NUC, chez un sujet infecté par l'HBC. L'invention concerne également des compositions et des méthodes d'utilisation de ces biomarqueurs immunogénétiques pour prédire la rechute dans le traitement de suppression virale d'une infection à HBC.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB18vT3dQzydg0KVnD0c1EIDXYNVgjxcA1y9XdT8PQDMRVCglwdQ3xd_UIUgGLOHkH-fp7OCh5OYUB5N1fnEE9_Px4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh_ub2RgZGRgYmlqYOJoZEycKgAR1Syr</recordid><startdate>20220310</startdate><enddate>20220310</enddate><creator>TUEFFERD, Marianne Isabelle</creator><creator>CRABBE, Marjolein</creator><creator>AERSSENS, Jeroen Marcel Maria Roger</creator><creator>BOLLEKENS, Jacques Armand Henri</creator><creator>DI CARA, Alessandro</creator><scope>EVB</scope></search><sort><creationdate>20220310</creationdate><title>BIOMARKERS AND USES THEREOF IN THE TREATMENT OF CHRONIC HBV INFECTION</title><author>TUEFFERD, Marianne Isabelle ; CRABBE, Marjolein ; AERSSENS, Jeroen Marcel Maria Roger ; BOLLEKENS, Jacques Armand Henri ; DI CARA, Alessandro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022049504A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>TUEFFERD, Marianne Isabelle</creatorcontrib><creatorcontrib>CRABBE, Marjolein</creatorcontrib><creatorcontrib>AERSSENS, Jeroen Marcel Maria Roger</creatorcontrib><creatorcontrib>BOLLEKENS, Jacques Armand Henri</creatorcontrib><creatorcontrib>DI CARA, Alessandro</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TUEFFERD, Marianne Isabelle</au><au>CRABBE, Marjolein</au><au>AERSSENS, Jeroen Marcel Maria Roger</au><au>BOLLEKENS, Jacques Armand Henri</au><au>DI CARA, Alessandro</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BIOMARKERS AND USES THEREOF IN THE TREATMENT OF CHRONIC HBV INFECTION</title><date>2022-03-10</date><risdate>2022</risdate><abstract>Immunogenetic biomarkers of viral control of chronic hepatitis B (CHB) infection that are indicative of relapse after a viral suppression treatment, such as a NUC treatment, in CHB infected subject are described. Also described are methods and compositions of using the immunogenetic biomarkers in predicting the relapse in the viral suppression treatment of CHB infection.
L'invention concerne des biomarqueurs immunogénétiques de la régulation virale d'une infection à hépatite B chronique (HBC) qui indiquent une rechute après un traitement de suppression virale, tel qu'un traitement par NUC, chez un sujet infecté par l'HBC. L'invention concerne également des compositions et des méthodes d'utilisation de ces biomarqueurs immunogénétiques pour prédire la rechute dans le traitement de suppression virale d'une infection à HBC.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2022049504A2 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE |
| title | BIOMARKERS AND USES THEREOF IN THE TREATMENT OF CHRONIC HBV INFECTION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A34%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TUEFFERD,%20Marianne%20Isabelle&rft.date=2022-03-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022049504A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |